Marketers to be liable for violation of rules by pharma companies Industry-The Economic Times — May 22, 2018 comments off The move is expected to check lapses in quality of medicines consumed by patients in the country, according to persons aware of the development.
The move is expected to check lapses in quality of medicines consumed by patients in the country, according to persons aware of the development.